RxDoctor Payments Data

Veronica Sharp, PA

Physician Assistant · Bryson City, NCNPI 1174075329

Payments from drug & device makers

$8,960in general payments, 2019–2025

Across 450 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Amgen$893
  • Corcept Therapeutics$687
  • Radius Health, Inc.$685
  • AbbVie$657
  • Lilly USA, LLC$598
  • plus $4K from 37 others

What the payments were for

  • Speaking & faculty fees$1251%
  • Food & beverage$8,54695%
  • Education$140%
  • Other$2753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,960 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,955
Medicare patients
324
Services billed
782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide74$174,005
ProliaDenosumab52$80,834
SynthroidLevothyroxine Sodium559$45,303
ForteoTeriparatide13$44,851
TrulicityDulaglutide40$37,945
JardianceEmpagliflozin42$31,978
Evenity (2 Syringes)Romosozumab-Aqqg13$31,888
MounjaroTirzepatide19$25,953
FarxigaDapagliflozin Propanediol24$16,614
OzempicSemaglutide19$15,102
TirosintLevothyroxine Sodium26$4,164
Levothyroxine Sodium382$3,113
Insulin Lispro Kwikpen U-100Insulin Lispro11$1,544
UnithroidLevothyroxine Sodium46$1,359
Liothyronine Sodium32$941

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$685$174,00574 claims
AmgenProlia, Evenity (2 Syringes)$893$112,72165 claims
Lilly USA, LLCForteo, Trulicity, Mounjaro$598$108,74972 claims
AbbVieSynthroid$657$45,303559 claims
Boehringer IngelheimJardiance$46$31,97842 claims
AstraZenecaFarxiga$587$16,61424 claims
Novo NordiskOzempic$544$15,10219 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$77$4,472428 claims
IBSA Pharma Inc.Tirosint$239$4,16426 claims
PfizerLevoxyl$144$70711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Bryson City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →